Zions Bancorp board member buys up shares amid slide in regional-bank stocks
By Emily Bary
Director Claire Huang purchased 18,000 shares Thursday for about $360,000 and reported another $120,000 in purchases for her spouse
A Zions Bancorp director last week made her first purchase of the company's stock since joining the board, as shares sold off amid pressure on regional-banking names, according to a MarketWatch review of filing data.
Claire Huang, a Zions (ZION) director, bought 18,000 shares Thursday for an average price of $20.021, paying $360,000 in the transaction, according to a filing with the Securities and Exchange Commission released Monday. She also reported the purchase of an additional 6,000 shares at an average price of $19.984 that was conducted Thursday by her spouse, a transaction with a value of just under $120,000.
A MarketWatch review of past Form 4 filings for Huang showed no prior open-market purchases or sales of the company's stock since she joined the board in 2020.
Past filings indicated that she was awarded shares as deferred compensation for her board role at various points each year. As of March 2, 2023, Huang owned 11,449 common shares, according to Zion's proxy statement filed March 23, 2023.
Zions has not responded to a MarketWatch request for comment Monday night on Huang's Thursday transaction.
Huang's purchase of Zions shares came as regional-banking names fell under continued pressure last week following JPMorgan Chase & Co.'s (JPM)takeover of First Republic Bank. That deal fueled concerns about instability in the regional-bank landscape.
Shares of Zions dropped 18.7% from the close of trading Friday, April 28, to the close Wednesday, May 3. Zions' stock fell another 12% Thursday, the day of Huang's purchase, before rallying 21.7% across the next two sessions.
See also: Zions, Western Alliance stocks soar after J.P. Morgan says buy, because they are 'substantially mispriced'
Huang joined Rebecca Robinson, the company's director of wealth management, who bought up just over $200,000 worth of Zions' stock on Thursday, according to a filing made public Friday.
Don't miss: KeyCorp executive buys up stock amid regional-bank selloff
Zions' stock has shed just over half its value so far this year, as the S&P 500 has advanced about 8%.
-Emily Bary
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-09-23 0933ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
Will Earnings From These 10 AI Stocks Live Up to the Hype?
-
What’s Happening In the Markets This Week
-
What the Next Bitcoin Halving Means for ETF Investors
-
Going Into Earnings, Is Microsoft a Buy, a Sell, or Fairly Valued?
-
ServiceNow Earnings: Strong Quarter With In-Line Guidance and Increasingly Attractive Valuation
-
Ford Earnings: Pro Continues to Impress While EV Costs Are Contained
-
Boeing Earnings: Paying for Mistakes Made Long Ago, Taking Back the Factory Floor
-
Meta Earnings: Stock Now Fairly Valued After Latest Selloff
-
March PCE Inflation Index Forecasts Show Mixed Readings On Price Pressures
-
After Earnings, Is Charles Schwab Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Apple Stock a Buy, a Sell, or Fairly Valued?
-
AT&T Earnings: Network Outage Didn’t Stop Solid Growth or Cash Flow